Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Metastatic colorectal cancer prior to expanded RAS assessment: evidence from long-term outcome analysis of a real-life cohort within a dedicated colorectal cancer unit.

Bertero L, Spadi R, Osella-Abate S, Mariani S, Castellano I, Gambella A, Racca P, Morino M, Cassoni P.

World J Surg Oncol. 2020 Apr 2;18(1):65. doi: 10.1186/s12957-020-01844-5.

2.

Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis.

Mirian C, Duun-Henriksen AK, Juratli T, Sahm F, Spiegl-Kreinecker S, Peyre M, Biczok A, Tonn JC, Goutagny S, Bertero L, Maier AD, Møller Pedersen M, Law I, Broholm H, Cahill DP, Brastianos P, Poulsgaard L, Fugleholm K, Ziebell M, Munch T, Mathiesen T.

J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):378-387. doi: 10.1136/jnnp-2019-322257. Epub 2020 Feb 10. Review.

PMID:
32041819
3.

Long-term survival of a sacro-coccygeal myxopapillary ependymoma with extra-neural metastases: case report and review of the literature.

Bruno F, Pellerino A, Bertero L, Soffietti R, Rudà R.

Neurol Sci. 2020 Jan 28. doi: 10.1007/s10072-020-04269-w. [Epub ahead of print] No abstract available.

PMID:
31989347
4.

NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target.

Gambella A, Senetta R, Collemi G, Vallero SG, Monticelli M, Cofano F, Zeppa P, Garbossa D, Pellerino A, Rudà R, Soffietti R, Fagioli F, Papotti M, Cassoni P, Bertero L.

Int J Mol Sci. 2020 Jan 23;21(3). pii: E753. doi: 10.3390/ijms21030753. Review.

5.

Choosing appropriate chemotherapy for diffusely infiltrating WHO grade II gliomas in adults.

Pellerino A, Bertero L, Rudà R, Soffietti R.

Expert Opin Pharmacother. 2020 Jan 20:1-3. doi: 10.1080/14656566.2020.1714030. [Epub ahead of print] No abstract available.

PMID:
31957509
6.

The Targeted Therapies Era Beyond the Surgical Point of View: What Spine Surgeons Should Know Before Approaching Spinal Metastases.

Cofano F, Monticelli M, Ajello M, Zenga F, Marengo N, Di Perna G, Altieri R, Cassoni P, Bertero L, Melcarne A, Tartara F, Ducati A, Garbossa D.

Cancer Control. 2019 Jan-Dec;26(1):1073274819870549. doi: 10.1177/1073274819870549.

7.

Integration of Ki-67 index into AJCC 2018 staging provides additional prognostic information in breast tumours candidate for genomic profiling.

Vissio E, Metovic J, Osella-Abate S, Bertero L, Migliaretti G, Borella F, Benedetto C, Sapino A, Cassoni P, Castellano I.

Br J Cancer. 2020 Feb;122(3):382-387. doi: 10.1038/s41416-019-0656-6. Epub 2019 Nov 29.

8.

Osteomyelitis of the pubic symphysis caused by methicillin-resistant Staphylococcus aureus after vaginal delivery: a case report and literature review.

Cosma S, Borella F, Carosso A, Ingala A, Fassio F, Robba T, Maina A, Bertero L, Benedetto C.

BMC Infect Dis. 2019 Nov 8;19(1):952. doi: 10.1186/s12879-019-4595-x. Review.

9.

Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016.

Rudà R, Pellerino A, Pace A, Carapella CM, Dealis C, Caroli M, Faedi M, Bello L, Migliore E, Marchese G, Bertero L, Cassoni P, Soffietti R.

J Neurooncol. 2019 Dec;145(3):593. doi: 10.1007/s11060-019-03331-8.

PMID:
31691059
10.

Resident memory T cells: Possible players in periodontal disease recurrence.

Deli F, Romano F, Gualini G, Mariani GM, Sala I, Veneziano F, Bertero L, Cassoni P, Aimetti M.

J Periodontal Res. 2020 Apr;55(2):324-330. doi: 10.1111/jre.12709. Epub 2019 Nov 2.

PMID:
31677275
11.

Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016.

Rudà R, Pellerino A, Pace A, Carapella CM, Dealis C, Caroli M, Faedi M, Bello L, Migliore E, Marchese G, Bertero L, Cassoni P, Soffietti R.

J Neurooncol. 2019 Oct;145(1):115-123. doi: 10.1007/s11060-019-03277-x. Epub 2019 Sep 25. Erratum in: J Neurooncol. 2019 Dec;145(3):593.

PMID:
31556015
12.

Clinico-pathological features of gynecological myopericytoma: a challenging diagnosis in an exceptional location.

Borella F, Lucchino F, Bertero L, Ribotta M, Castellano I, Carosso A, Cosma S, Katsaros D, Benedetto C.

Virchows Arch. 2019 Dec;475(6):763-770. doi: 10.1007/s00428-019-02645-2. Epub 2019 Aug 13.

PMID:
31410559
13.

Phenotypic characterisation of immune cells associated with histological regression in cutaneous melanoma.

Osella-Abate S, Conti L, Annaratone L, Senetta R, Bertero L, Licciardello M, Caliendo V, Picciotto F, Quaglino P, Cassoni P, Ribero S.

Pathology. 2019 Aug;51(5):487-493. doi: 10.1016/j.pathol.2019.04.001. Epub 2019 Jun 29.

14.

SEL1L plays a major role in human malignant gliomas.

Mellai M, Annovazzi L, Boldorini R, Bertero L, Cassoni P, De Blasio P, Biunno I, Schiffer D.

J Pathol Clin Res. 2020 Jan;6(1):17-29. doi: 10.1002/cjp2.134. Epub 2019 Sep 30.

15.

Review: Peering through a keyhole: liquid biopsy in primary and metastatic central nervous system tumours.

Bertero L, Siravegna G, Rudà R, Soffietti R, Bardelli A, Cassoni P.

Neuropathol Appl Neurobiol. 2019 Dec;45(7):655-670. doi: 10.1111/nan.12553. Epub 2019 May 14. Review.

16.

TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk.

Osella-Abate S, Bertero L, Senetta R, Mariani S, Lisa F, Coppola V, Metovic J, Pasini B, Puig S S, Fierro MT, Manrique-Silva E, Kumar R, Nagore E, Cassoni P, Ribero S.

Cancers (Basel). 2019 Mar 30;11(4). pii: E452. doi: 10.3390/cancers11040452.

17.

Spinal epidural capillary hemangioma: case report and review of the literature.

Cofano F, Marengo N, Pecoraro F, Penner F, Bertero L, Zenga F.

Br J Neurosurg. 2019 Mar 4:1-4. doi: 10.1080/02688697.2018.1562034. [Epub ahead of print]

PMID:
30829069
18.

Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA.

Hou Y, Pinheiro J, Sahm F, Reuss DE, Schrimpf D, Stichel D, Casalini B, Koelsche C, Sievers P, Wefers AK, Reinhardt A, Ebrahimi A, Fernández-Klett F, Pusch S, Meier J, Schweizer L, Paulus W, Prinz M, Hartmann C, Plate KH, Reifenberger G, Pietsch T, Varlet P, Pagès M, Schüller U, Scheie D, de Stricker K, Frank S, Hench J, Pollo B, Brandner S, Unterberg A, Pfister SM, Jones DTW, Korshunov A, Wick W, Capper D, Blümcke I, von Deimling A, Bertero L.

Acta Neuropathol. 2019 May;137(5):837-846. doi: 10.1007/s00401-019-01969-2. Epub 2019 Feb 13.

PMID:
30759284
19.

Prognostic Characterization of Higher-Grade Meningiomas: A Histopathological Score to Predict Progression and Outcome.

Bertero L, Dalla Dea G, Osella-Abate S, Botta C, Castellano I, Morra I, Pollo B, Calatozzolo C, Patriarca S, Mantovani C, Rudà R, Tardivo V, Zenga F, Garbossa D, Papotti M, Soffietti R, Ricardi U, Cassoni P.

J Neuropathol Exp Neurol. 2019 Mar 1;78(3):248-256. doi: 10.1093/jnen/nly127.

20.

HIV-1 detection in the olfactory mucosa of HIV-1-infected participants.

Bertero L, Joseph SB, Trunfio M, Allice T, Catera S, Imperiale D, Cassoni P, Kincer LP, Pirriatore V, Ghisetti V, Amasio E, Zanusso G, Bonora S, Di Perri G, Calcagno A.

AIDS. 2019 Mar 15;33(4):665-674. doi: 10.1097/QAD.0000000000002102.

PMID:
30608272
21.

ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas.

Osella-Abate S, Mereu E, Pellegrino E, Bergaggio E, Ribero S, Bertero L, Lisa F, Fierro MT, Giulio Papotti M, Piva R.

Oncol Lett. 2018 Dec;16(6):7091-7096. doi: 10.3892/ol.2018.9560. Epub 2018 Oct 9.

22.

Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness.

Ribero S, Galli F, Osella-Abate S, Bertero L, Cattaneo L, Merelli B, Tondini C, Ghilardi L, De Giorgi V, Occelli M, Quaglino P, Cassoni P, Palmieri G, Massi D, Mandala M; Italian Melanoma Intergroup.

J Am Acad Dermatol. 2019 Jan;80(1):99-105.e5. doi: 10.1016/j.jaad.2018.06.054. Epub 2018 Nov 14.

PMID:
30447951
23.

The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas.

Schiffer D, Mellai M, Boldorini R, Bisogno I, Grifoni S, Corona C, Bertero L, Cassoni P, Casalone C, Annovazzi L.

Int J Mol Sci. 2018 Sep 12;19(9). pii: E2724. doi: 10.3390/ijms19092724. Review.

24.

Pathological prognostic markers in central nervous system solitary fibrous tumour/hemangiopericytoma: Evidence from a small series.

Bertero L, Anfossi V, Osella-Abate S, Disanto MG, Mantovani C, Zenga F, Rudà R, Garbossa D, Soffietti R, Ricardi U, Papotti M, Cassoni P.

PLoS One. 2018 Sep 5;13(9):e0203570. doi: 10.1371/journal.pone.0203570. eCollection 2018.

25.

Author Correction: STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis.

Priego N, Zhu L, Monteiro C, Mulders M, Wasilewski D, Bindeman W, Doglio L, Martínez L, Martínez-Saez E, Ramón Y Cajal S, Megías D, Hernández-Encinas E, Blanco-Aparicio C, Martínez L, Zarzuela E, Muñoz J, Fustero-Torre C, Piñeiro-Yáñez E, Hernández-Laín A, Bertero L, Poli V, Sanchez-Martinez M, Menendez JA, Soffietti R, Bosch-Barrera J, Valiente M.

Nat Med. 2018 Sep;24(9):1481. doi: 10.1038/s41591-018-0108-5.

PMID:
29921958
26.

STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis.

Priego N, Zhu L, Monteiro C, Mulders M, Wasilewski D, Bindeman W, Doglio L, Martínez L, Martínez-Saez E, Ramón Y Cajal S, Megías D, Hernández-Encinas E, Blanco-Aparicio C, Martínez L, Zarzuela E, Muñoz J, Fustero-Torre C, Piñeiro-Yáñez E, Hernández-Laín A, Bertero L, Poli V, Sanchez-Martinez M, Menendez JA, Soffietti R, Bosch-Barrera J, Valiente M.

Nat Med. 2018 Jul;24(7):1024-1035. doi: 10.1038/s41591-018-0044-4. Epub 2018 Jun 11. Erratum in: Nat Med. 2018 Jun 19;:.

PMID:
29892069
27.

Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations.

Koelsche C, Mynarek M, Schrimpf D, Bertero L, Serrano J, Sahm F, Reuss DE, Hou Y, Baumhoer D, Vokuhl C, Flucke U, Petersen I, Brück W, Rutkowski S, Zambrano SC, Garcia Leon JL, Diaz Coronado RY, Gessler M, Tirado OM, Mora J, Alonso J, Garcia Del Muro X, Esteller M, Sturm D, Ecker J, Milde T, Pfister SM, Korshunov A, Snuderl M, Mechtersheimer G, Schüller U, Jones DTW, von Deimling A.

Acta Neuropathol. 2018 Aug;136(2):327-337. doi: 10.1007/s00401-018-1871-6. Epub 2018 Jun 7.

28.

Safe transportation of formalin-fixed liquid-free pathology specimens.

Metovic J, Bertero L, Musuraca C, Veneziano F, Annaratone L, Mariani S, Cassoni P, Bussolati G, Papotti M.

Virchows Arch. 2018 Jul;473(1):105-113. doi: 10.1007/s00428-018-2383-4. Epub 2018 Jun 2.

PMID:
29860620
29.

The post-surgical era of GBM: How molecular biology has impacted on our clinical management. A review.

Monticelli M, Zeppa P, Zenga F, Altieri R, Mammi M, Bertero L, Castellano I, Cassoni P, Melcarne A, La Rocca G, Sabatino G, Ducati A, Garbossa D.

Clin Neurol Neurosurg. 2018 Jul;170:120-126. doi: 10.1016/j.clineuro.2018.05.015. Review.

30.

Awareness of mutational artefacts in suboptimal DNA samples: possible risk for therapeutic choices.

Mariani S, Bertero L, Coppola V, Saracco G, Arezzo A, Francia Di Celle P, Metovic J, Marchiò C, Cassoni P.

Expert Rev Mol Diagn. 2018 May;18(5):467-475. doi: 10.1080/14737159.2018.1468254. Epub 2018 Apr 26.

31.

Double cystic brain metastasis in a patient with stable pancreatic intraductal papillary mucinous neoplasm.

Tardivo V, Vincitorio F, Monticelli M, Bertero L, Zenga F, Ducati A, Cassoni P, Garbossa D.

Br J Neurosurg. 2018 Mar 20:1-5. doi: 10.1080/02688697.2018.1451824. [Epub ahead of print]

32.

Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments.

Pellerino A, Bertero L, Rudà R, Soffietti R.

Ther Adv Neurol Disord. 2018 Mar 7;11:1756286418759618. doi: 10.1177/1756286418759618. eCollection 2018. Review.

33.

Severe Multi-Organ Failure and Hypereosinophilia: When to Call It "Idiopathic"?

Radin M, Bertero L, Roccatello D, Sciascia S.

J Investig Med High Impact Case Rep. 2018 Feb 15;6:2324709618758347. doi: 10.1177/2324709618758347. eCollection 2018 Jan-Dec.

34.

The role of the AR/ER ratio in ER-positive breast cancer patients.

Rangel N, Rondon-Lagos M, Annaratone L, Osella-Abate S, Metovic J, Mano MP, Bertero L, Cassoni P, Sapino A, Castellano I.

Endocr Relat Cancer. 2018 Mar;25(3):163-172. doi: 10.1530/ERC-17-0417.

PMID:
29386247
35.

Expression analysis of HMGB1 in histological samples of malignant pleural mesothelioma.

Rrapaj E, Trisolini E, Bertero L, Salvo M, Indellicato R, Andorno S, Garcia-Manteiga JM, Rena O, Boldorini RL.

Histopathology. 2018 May;72(6):1039-1050. doi: 10.1111/his.13470. Epub 2018 Feb 26.

36.

A 68-Year-Old Woman with A Left Orbital and Temporal Mass.

Bertero L, Zenga F, Maletta F, Senetta R, Cassoni P.

Brain Pathol. 2018 Jan;28(1):133-134. doi: 10.1111/bpa.12580. No abstract available.

37.

Molecular alterations of neuroendocrine tumours of the lung.

Rossi G, Bertero L, Marchiò C, Papotti M.

Histopathology. 2018 Jan;72(1):142-152. doi: 10.1111/his.13394. Review.

PMID:
29239031
38.

Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why?

Bertero L, Massa F, Metovic J, Zanetti R, Castellano I, Ricardi U, Papotti M, Cassoni P.

Virchows Arch. 2018 Apr;472(4):519-531. doi: 10.1007/s00428-017-2276-y. Epub 2017 Dec 5. Review.

PMID:
29209757
39.

Mitochondrial DNA "common deletion" in post-fine needle aspiration infarcted oncocytic thyroid tumors.

Conti L, Vatrano S, Bertero L, Masu L, Pacchioni D, Daniele L, De Rosa G, Cassoni P, Volante M, Papotti M.

Hum Pathol. 2017 Nov;69:23-30. doi: 10.1016/j.humpath.2017.09.004. Epub 2017 Sep 27.

PMID:
28962946
40.

Distinctive pathological and clinical features of lung carcinoids with high proliferation index.

Marchiò C, Gatti G, Massa F, Bertero L, Filosso P, Pelosi G, Cassoni P, Volante M, Papotti M.

Virchows Arch. 2017 Dec;471(6):713-720. doi: 10.1007/s00428-017-2177-0. Epub 2017 Jun 19.

41.

Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene.

Mariani S, Bertero L, Osella-Abate S, Di Bello C, Francia di Celle P, Coppola V, Sapino A, Cassoni P, Marchiò C.

Br J Cancer. 2017 Jul 25;117(3):358-366. doi: 10.1038/bjc.2017.170. Epub 2017 Jun 15.

42.

Caveolin 1 expression favors tumor growth and is associated with poor survival in primary lung adenocarcinomas.

Duregon E, Senetta R, Bertero L, Bussolati B, Annaratone L, Pittaro A, Papotti M, Marchiò C, Cassoni P.

Tumour Biol. 2017 Feb;39(2):1010428317694311. doi: 10.1177/1010428317694311.

PMID:
28229621
43.

Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept.

Marchiò C, Mariani S, Bertero L, Di Bello C, Francia Di Celle P, Papotti M, Rudà R, Soffietti R, Cassoni P.

Neuro Oncol. 2017 Mar 1;19(3):451-453. doi: 10.1093/neuonc/now244. No abstract available.

44.

Successful use of bevacizumab in an adult primary diffuse leptomeningeal glioneuronal tumor.

Pellerino A, Rudà R, Bertero L, Magistrello M, Franchino F, Cassoni P, Pasqualetti F, Pinessi L, Giangaspero F, Soffietti R.

J Neurosurg Sci. 2018 Apr;62(2):229-232. doi: 10.23736/S0390-5616.16.03804-2. Epub 2016 Sep 27. No abstract available.

PMID:
27676284
45.

Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas.

Duregon E, Bertero L, Pittaro A, Soffietti R, Rudà R, Trevisan M, Papotti M, Ventura L, Senetta R, Cassoni P.

Oncotarget. 2016 Apr 19;7(16):21190-8. doi: 10.18632/oncotarget.8498.

46.

Mesenchymal/radioresistant traits in granular astrocytomas: evidence from a combined clinical and molecular approach.

Senetta R, Mellai M, Manini C, Castellano I, Bertero L, Pittaro A, Schiffer D, Boldorini R, Cassoni P.

Histopathology. 2016 Aug;69(2):329-37. doi: 10.1111/his.12944. Epub 2016 Mar 21.

PMID:
26845757
47.

Evaluation of low-grade glioma structural changes after chemotherapy using DTI-based histogram analysis and functional diffusion maps.

Castellano A, Donativi M, Rudà R, De Nunzio G, Riva M, Iadanza A, Bertero L, Rucco M, Bello L, Soffietti R, Falini A.

Eur Radiol. 2016 May;26(5):1263-73. doi: 10.1007/s00330-015-3934-6. Epub 2015 Aug 30.

PMID:
26318368
48.

Is there a Role for Bevacizumab in Non-Glial Tumors?

Trevisan E, Bertero L, Magistrello M, Rudà R, Soffietti R.

Curr Drug Targets. 2015;16(7):684-8.

PMID:
25808649
49.

Pharmacologic therapies for malignant glioma: a guide for clinicians.

Soffietti R, Bertero L, Pinessi L, Rudà R.

CNS Drugs. 2014 Dec;28(12):1127-37. doi: 10.1007/s40263-014-0215-x. Review.

PMID:
25403944
50.

Nocardia abscesses mimicking tumor progression in gliomatosis cerebri responding to temozolomide.

Bertero L, Cassoni P, Rudà R.

J Neurooncol. 2015 Jan;121(1):225-7. doi: 10.1007/s11060-014-1609-9. Epub 2014 Sep 5. No abstract available.

Supplemental Content

Loading ...
Support Center